Join AEI as an expert panel examines how changing the tax advantages for spending on health might lower health care spending, increase health-related social spending, and improve health outcomes.
What is a sensible model for regulating electronic cigarettes, nicotine-containing products that are far safer than conventional cigarettes?
Proponents of change need to avoid imagining they are taking another step forward when they might be taking two steps backward. Here’s some further homework for would be health care reformers.
On Fox News’ ‘America’s Newsroom,’ Jonah Goldberg discussed the GOP health care bill.
There are less than forty shopping days before the next drop-dead date for the August recess, and political dismay springs eternal. So what have we learned so far about health care politics?
The Better Care Reconciliation Act (BCRA) isn’t perfect, but it also isn’t finished. Overall the BCRA is a good step toward re-establishing the flexibility and experimentation that our Constitution encourages.
The Senate healthcare bill has faced a lot of opposition from both Democrats and Republicans. The bill needs to be improved in a number ways. It doesn’t do enough to bring discipline to cost in the system, make sure that people in the very low end can get affordable coverage, and it needs to bring competition into the system.
Journalists tend to celebrate deals and initiatives in part because of their inherent drama, yet this approach will inevitably skew an accurate telling of the true amount of effort required for both success and failure.
Donald Trump and Senate Republicans are focusing on pushing the health care bill along and getting the needed votes in order to keep campaign promises and move on with the agenda.
The Senate’s Medicaid reforms are not perfect — but they are an important step toward making the American health-care system affordable for taxpayers.
A fundamental overhaul of India’s drug regulatory structure is needed to ensure that US drug supply, which depends on Indian manufacturing facilities, is not at risk.
Anna Edney wrote an interesting article in Bloomberg today about the problems with generic medicine.